InvestorsHub Logo
Followers 30
Posts 2784
Boards Moderated 0
Alias Born 09/14/2012

Re: None

Wednesday, 01/15/2014 12:33:24 PM

Wednesday, January 15, 2014 12:33:24 PM

Post# of 18443
This is just my opinion on JJ's presentation. It seemed to me that Aethlon is now placing a lot of weight on exosomes. JJ discussed more about other uses and avenues for the hemopurifier then Hep C alone. He talks about two new larger companies now in the works for the FDA IDE? I'm guessing that the other two (Larger)companies are associated to cancer and exosomes. I feel that JJ sees more revenue with cancer and exosomes and Hep C is now running third. This may be wishful thinking, but MD Anderson and Pfizer just joined as partners in the Moon Shot Program. About 75% of JJ presentation is about cancer and exosomes. JJ announced a change in the FDA IDE study to two larger companies. Yes, I'm still stuck on MD Anderson being associated with Aethlon and ESI. Lets hope we find out soon.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News